Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

STAAR Surgical Company - Common Stock (NQ:STAA)

26.95 +0.05 (+0.19%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 7, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about STAAR Surgical Company - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
The Latest Analyst Ratings for Staar Surgical
 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 17, 2023
 
Via Benzinga
STAAR Surgical Names Warren Foust Chief Operating Officer; Magda Michna, Ph.D., Chief Clinical, Regulatory and Medical Affairs Officer
From STAAR Surgical Company
Via Business Wire
Expert Ratings for Staar Surgical
 
Via Benzinga
Staar Surgical Earnings Preview
 
Via Benzinga
Analyst Expectations for Staar Surgical's Future
 
Via Benzinga
Stephens & Co. Maintains Overweight Rating for Staar Surgical: Here's What You Need To Know
 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
 
Via Benzinga
STAAR Surgical Reports Fourth Quarter and Fiscal Year 2022 Results
From STAAR Surgical Company
Via Business Wire
STAAR Surgical to Report Fourth Quarter and Fiscal Year Results on February 21, 2023
From STAAR Surgical Company
Via Business Wire
Analyst Reiterates This Ophthalmology Device Stock On Steep But Attractive Risk/Reward
Needham analyst expects the U.S. ICL market of more than $2.4 billion, despite some investors considering the market to be niche, with STAAR Surgical Company (NASDAQ: STAA) becoming a major player in... 
Via Benzinga
7 Analysts Have This to Say About Staar Surgical
 
Via Benzinga
What 6 Analyst Ratings Have To Say About Staar Surgical
 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 6, 2023
 
Via Benzinga
Neogen Stock Earns Relative Strength Rating Upgrade
Neogen stock got a positive adjustment to its Relative Strength (RS) Rating, rising to 79 on Thursday from 66 a day earlier. 
Via Investor's Business Daily
Actress and Beauty Entrepreneur Peyton List Sets Her Sights on 2023 with Upgraded Vision from Life-Changing EVO ICL Lenses
From STAAR Surgical Company
Via Business Wire
STAAR Surgical Reports Preliminary Sales for Fourth Quarter and Fiscal 2022
From STAAR Surgical Company
Via Business Wire
Why Shares of STAAR Surgical Jumped 23.7% This Week
The new CEO made a major purchase of the company's stock on Monday. 
Via The Motley Fool
Goldman Sachs To $492? Here Are 10 Other Price Target Changes For Wednesday
 
Via Benzinga
STAAR Surgical CEO Caren Mason to Retire; Tom Frinzi Appointed New CEO
From STAAR Surgical Company
Via Business Wire
Stocks That Hit 52-Week Lows On Tuesday
  On Tuesday, 298 companies achieved new lows for the year. 
Via Benzinga
STAAR Surgical Opens EVO Experience Center in United States
From STAAR Surgical Company
Via Business Wire
Kellogg, Palo Alto Networks, Roku And Other Big Losers From Thursday
U.S. stocks closed lower on Thursday, with the Dow Jones dropping more than 100 points. Here is the list of some big stocks recording losses in the previous session. 
Via Benzinga
What 8 Analyst Ratings Have To Say About Staar Surgical
Over the past 3 months, 8 analysts have published their opinion on Staar Surgical (NASDAQ:STAA) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... 
Via Benzinga
Why Greenhill Shares Climbed Around 25%; Here Are 100 Biggest Movers From Yesterday
Gainers Huadi International Group Co., Ltd. (NASDAQ: HUDI) shares jumped 242.8% to close at $105.72 on Thursday. The company announced a strategic plan to enter into the clean energy industry. 
Via Benzinga
Humana To Rally Over 14%? Here Are 5 Other Price Target Changes For Thursday
SVB Leerink raised Humana Inc. (NYSE: HUM) price target from $540 to $640. SVB Leerink analyst Whit Mayo maintained the stock with an Outperform rating. Humana shares rose 0.9% to close at $559.58 on... 
Via Benzinga
STAAR Surgical Reports Third Quarter Net Sales of $76 Million Up 30% Y/Y
From STAAR Surgical Company
Via Business Wire
STAAR Surgical to Report Third Quarter Results on November 2, 2022
From STAAR Surgical Company
Via Business Wire
Tesla To $230? Plus Canaccord Genuity Cuts PT On T2 Biosystems By 80%
Wells Fargo cut the price target on Tesla, Inc. (NASDAQ: TSLA) from $280 to $230. Wells Fargo analyst Colin Langan maintained an Equal-Weight rating on the stock. Tesla shares fell 0.4% to $220.85 in... 
Via Benzinga
Earnings Scheduled For November 2, 2022
Companies Reporting Before The Bell • Nomura Holdings (NYSE:NMR) is likely to report earnings for its second quarter. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.